PDB Short entry for 1F1J HEADER APOPTOSIS, HYDROLASE/HYDROLASE INHIBITOR19-MAY-00 1F1J TITLE CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP- TITLE 2 CHO COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-7 PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: P20/P10 CATALYTIC DOMAIN; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ACE-ASP-GLU-VAL-ASP-CHO; COMPND 9 CHAIN: C, D; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 OTHER_DETAILS: THIS SEQUENCE WAS CHEMICALLY SYNTHESIZED KEYWDS CASPASE-7, CYSTEINE PROTEASE, HYDROLASE, APOPTOSIS, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.WEI,P.S.CHARIFSON REVDAT 4 03-JUL-13 1F1J 1 HET HETATM HETNAM REMARK REVDAT 4 2 1 SEQRES REVDAT 3 13-JUL-11 1F1J 1 VERSN REVDAT 2 24-FEB-09 1F1J 1 VERSN REVDAT 1 23-MAY-01 1F1J 0 JRNL AUTH Y.WEI,T.FOX,S.P.CHAMBERS,J.SINTCHAK,J.T.COLL,J.M.GOLEC, JRNL AUTH 2 L.SWENSON,K.P.WILSON,P.S.CHARIFSON JRNL TITL THE STRUCTURES OF CASPASES-1, -3, -7 AND -8 REVEAL THE BASIS JRNL TITL 2 FOR SUBSTRATE AND INHIBITOR SELECTIVITY. JRNL REF CHEM.BIOL. V. 7 423 2000 JRNL REFN ISSN 1074-5521 JRNL PMID 10873833 JRNL DOI 10.1016/S1074-5521(00)00123-X REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.843 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.500 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 33303 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1665 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3757 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 397 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.80 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.40 REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1F1J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JUN-00. REMARK 100 THE RCSB ID CODE IS RCSB011129. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-SEP-98 REMARK 200 TEMPERATURE (KELVIN) : 128 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.10 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRANDEIS - B4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34359 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000, 0.1 M NA-CITRATE, 0.2 M REMARK 280 AMMONIUM ACETATE, PH 7.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 124.15333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.07667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.07667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 124.15333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 14520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -102.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 62.07667 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 88.18000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THERE IS A COVALENT BOND BETWEEN ATOM SG OF CYS186A AND ATOM C OF REMARK 400 ASA705C, AND SAME BOND BETWEEN ATOM SG OF CYS486B AND ATOM C OF REMARK 400 ASA805D, FORMING THIOHEMIACETAL REMARK 400 REMARK 400 THE AC-ASP-GLU-VAL-ASP-ALDEHYDE IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: AC-ASP-GLU-VAL-ASP-ALDEHYDE REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -1 REMARK 465 LEU A 0 REMARK 465 GLU A 1 REMARK 465 ALA A 2 REMARK 465 ASP A 3 REMARK 465 ASP A 4 REMARK 465 GLN A 5 REMARK 465 GLY A 6 REMARK 465 CYS A 7 REMARK 465 ILE A 8 REMARK 465 GLU A 9 REMARK 465 GLU A 10 REMARK 465 GLN A 11 REMARK 465 GLY A 12 REMARK 465 VAL A 13 REMARK 465 GLU A 14 REMARK 465 ASP A 15 REMARK 465 SER A 16 REMARK 465 ALA A 17 REMARK 465 ASN A 18 REMARK 465 GLU A 19 REMARK 465 ASP A 20 REMARK 465 SER A 21 REMARK 465 VAL A 22 REMARK 465 ASP A 23 REMARK 465 ALA A 24 REMARK 465 LYS A 25 REMARK 465 PRO A 26 REMARK 465 ASP A 27 REMARK 465 ARG A 28 REMARK 465 SER A 29 REMARK 465 SER A 30 REMARK 465 PHE A 31 REMARK 465 VAL A 32 REMARK 465 PRO A 33 REMARK 465 SER A 34 REMARK 465 LEU A 35 REMARK 465 PHE A 36 REMARK 465 SER A 37 REMARK 465 LYS A 38 REMARK 465 LYS A 39 REMARK 465 LYS A 40 REMARK 465 LYS A 41 REMARK 465 ASN A 42 REMARK 465 VAL A 43 REMARK 465 THR A 44 REMARK 465 MET A 45 REMARK 465 ARG A 46 REMARK 465 SER A 47 REMARK 465 ILE A 48 REMARK 465 LYS A 49 REMARK 465 THR A 50 REMARK 465 THR A 51 REMARK 465 ARG A 52 REMARK 465 ASP A 53 REMARK 465 ARG A 54 REMARK 465 VAL A 55 REMARK 465 PRO A 56 REMARK 465 THR A 57 REMARK 465 ALA A 197 REMARK 465 ASP A 198 REMARK 465 SER A 199 REMARK 465 GLY A 200 REMARK 465 PRO A 201 REMARK 465 ILE A 202 REMARK 465 ASN A 203 REMARK 465 ASP A 204 REMARK 465 THR A 205 REMARK 465 ASP A 206 REMARK 465 ALA A 207 REMARK 465 ASN A 208 REMARK 465 PRO A 209 REMARK 465 ARG A 210 REMARK 465 TYR A 211 REMARK 465 GLN A 303 REMARK 465 MET B 299 REMARK 465 LEU B 300 REMARK 465 GLU B 301 REMARK 465 ALA B 302 REMARK 465 ASP B 303 REMARK 465 ASP B 304 REMARK 465 GLN B 305 REMARK 465 GLY B 306 REMARK 465 CYS B 307 REMARK 465 ILE B 308 REMARK 465 GLU B 309 REMARK 465 GLU B 310 REMARK 465 GLN B 311 REMARK 465 GLY B 312 REMARK 465 VAL B 313 REMARK 465 GLU B 314 REMARK 465 ASP B 315 REMARK 465 SER B 316 REMARK 465 ALA B 317 REMARK 465 ASN B 318 REMARK 465 GLU B 319 REMARK 465 ASP B 320 REMARK 465 SER B 321 REMARK 465 VAL B 322 REMARK 465 ASP B 323 REMARK 465 ALA B 324 REMARK 465 LYS B 325 REMARK 465 PRO B 326 REMARK 465 ASP B 327 REMARK 465 ARG B 328 REMARK 465 SER B 329 REMARK 465 SER B 330 REMARK 465 PHE B 331 REMARK 465 VAL B 332 REMARK 465 PRO B 333 REMARK 465 SER B 334 REMARK 465 LEU B 335 REMARK 465 PHE B 336 REMARK 465 SER B 337 REMARK 465 LYS B 338 REMARK 465 LYS B 339 REMARK 465 LYS B 340 REMARK 465 LYS B 341 REMARK 465 ASN B 342 REMARK 465 VAL B 343 REMARK 465 THR B 344 REMARK 465 MET B 345 REMARK 465 ARG B 346 REMARK 465 SER B 347 REMARK 465 ILE B 348 REMARK 465 LYS B 349 REMARK 465 THR B 350 REMARK 465 THR B 351 REMARK 465 ARG B 352 REMARK 465 ASP B 353 REMARK 465 ARG B 354 REMARK 465 VAL B 355 REMARK 465 PRO B 356 REMARK 465 ALA B 497 REMARK 465 ASP B 498 REMARK 465 SER B 499 REMARK 465 GLY B 500 REMARK 465 PRO B 501 REMARK 465 ILE B 502 REMARK 465 ASN B 503 REMARK 465 ASP B 504 REMARK 465 THR B 505 REMARK 465 ASP B 506 REMARK 465 ALA B 507 REMARK 465 ASN B 508 REMARK 465 PRO B 509 REMARK 465 ARG B 510 REMARK 465 TYR B 511 REMARK 465 GLN B 603 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER A 234 N - CA - CB ANGL. DEV. = -11.1 DEGREES REMARK 500 LEU B 422 CA - CB - CG ANGL. DEV. = 16.4 DEGREES REMARK 500 GLY B 452 N - CA - C ANGL. DEV. = -16.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 113 45.36 27.97 REMARK 500 SER A 143 -169.43 -177.07 REMARK 500 PRO A 289 -171.49 -66.18 REMARK 500 CYS B 436 -168.61 -168.27 REMARK 500 SER B 443 -176.30 -171.52 REMARK 500 GLU B 574 113.11 -165.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 851 DISTANCE = 5.28 ANGSTROMS REMARK 525 HOH B 858 DISTANCE = 5.73 ANGSTROMS REMARK 525 HOH B1020 DISTANCE = 5.48 ANGSTROMS REMARK 525 HOH B1105 DISTANCE = 8.22 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF ACE-ASP-GLU-VAL-ASP- REMARK 800 CHO REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF ACE-ASP-GLU-VAL-ASP- REMARK 800 CHO DBREF 1F1J A 2 303 UNP P55210 ICE7_HUMAN 2 303 DBREF 1F1J B 302 603 UNP P55210 ICE7_HUMAN 2 303 DBREF 1F1J C 701 705 PDB 1F1J 1F1J 701 705 DBREF 1F1J D 801 805 PDB 1F1J 1F1J 801 805 SEQADV 1F1J MET A -1 UNP P55210 CLONING ARTIFACT SEQADV 1F1J LEU A 0 UNP P55210 CLONING ARTIFACT SEQADV 1F1J GLU A 1 UNP P55210 MET 1 CONFLICT SEQADV 1F1J SER A 171 UNP P55210 CYS 171 CONFLICT SEQADV 1F1J MET B 299 UNP P55210 CLONING ARTIFACT SEQADV 1F1J LEU B 300 UNP P55210 CLONING ARTIFACT SEQADV 1F1J GLU B 301 UNP P55210 MET 1 CONFLICT SEQADV 1F1J SER B 471 UNP P55210 CYS 171 CONFLICT SEQRES 1 A 305 MET LEU GLU ALA ASP ASP GLN GLY CYS ILE GLU GLU GLN SEQRES 2 A 305 GLY VAL GLU ASP SER ALA ASN GLU ASP SER VAL ASP ALA SEQRES 3 A 305 LYS PRO ASP ARG SER SER PHE VAL PRO SER LEU PHE SER SEQRES 4 A 305 LYS LYS LYS LYS ASN VAL THR MET ARG SER ILE LYS THR SEQRES 5 A 305 THR ARG ASP ARG VAL PRO THR TYR GLN TYR ASN MET ASN SEQRES 6 A 305 PHE GLU LYS LEU GLY LYS CYS ILE ILE ILE ASN ASN LYS SEQRES 7 A 305 ASN PHE ASP LYS VAL THR GLY MET GLY VAL ARG ASN GLY SEQRES 8 A 305 THR ASP LYS ASP ALA GLU ALA LEU PHE LYS CYS PHE ARG SEQRES 9 A 305 SER LEU GLY PHE ASP VAL ILE VAL TYR ASN ASP CYS SER SEQRES 10 A 305 CYS ALA LYS MET GLN ASP LEU LEU LYS LYS ALA SER GLU SEQRES 11 A 305 GLU ASP HIS THR ASN ALA ALA CYS PHE ALA CYS ILE LEU SEQRES 12 A 305 LEU SER HIS GLY GLU GLU ASN VAL ILE TYR GLY LYS ASP SEQRES 13 A 305 GLY VAL THR PRO ILE LYS ASP LEU THR ALA HIS PHE ARG SEQRES 14 A 305 GLY ASP ARG SER LYS THR LEU LEU GLU LYS PRO LYS LEU SEQRES 15 A 305 PHE PHE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP ASP SEQRES 16 A 305 GLY ILE GLN ALA ASP SER GLY PRO ILE ASN ASP THR ASP SEQRES 17 A 305 ALA ASN PRO ARG TYR LYS ILE PRO VAL GLU ALA ASP PHE SEQRES 18 A 305 LEU PHE ALA TYR SER THR VAL PRO GLY TYR TYR SER TRP SEQRES 19 A 305 ARG SER PRO GLY ARG GLY SER TRP PHE VAL GLN ALA LEU SEQRES 20 A 305 CYS SER ILE LEU GLU GLU HIS GLY LYS ASP LEU GLU ILE SEQRES 21 A 305 MET GLN ILE LEU THR ARG VAL ASN ASP ARG VAL ALA ARG SEQRES 22 A 305 HIS PHE GLU SER GLN SER ASP ASP PRO HIS PHE HIS GLU SEQRES 23 A 305 LYS LYS GLN ILE PRO CYS VAL VAL SER MET LEU THR LYS SEQRES 24 A 305 GLU LEU TYR PHE SER GLN SEQRES 1 B 305 MET LEU GLU ALA ASP ASP GLN GLY CYS ILE GLU GLU GLN SEQRES 2 B 305 GLY VAL GLU ASP SER ALA ASN GLU ASP SER VAL ASP ALA SEQRES 3 B 305 LYS PRO ASP ARG SER SER PHE VAL PRO SER LEU PHE SER SEQRES 4 B 305 LYS LYS LYS LYS ASN VAL THR MET ARG SER ILE LYS THR SEQRES 5 B 305 THR ARG ASP ARG VAL PRO THR TYR GLN TYR ASN MET ASN SEQRES 6 B 305 PHE GLU LYS LEU GLY LYS CYS ILE ILE ILE ASN ASN LYS SEQRES 7 B 305 ASN PHE ASP LYS VAL THR GLY MET GLY VAL ARG ASN GLY SEQRES 8 B 305 THR ASP LYS ASP ALA GLU ALA LEU PHE LYS CYS PHE ARG SEQRES 9 B 305 SER LEU GLY PHE ASP VAL ILE VAL TYR ASN ASP CYS SER SEQRES 10 B 305 CYS ALA LYS MET GLN ASP LEU LEU LYS LYS ALA SER GLU SEQRES 11 B 305 GLU ASP HIS THR ASN ALA ALA CYS PHE ALA CYS ILE LEU SEQRES 12 B 305 LEU SER HIS GLY GLU GLU ASN VAL ILE TYR GLY LYS ASP SEQRES 13 B 305 GLY VAL THR PRO ILE LYS ASP LEU THR ALA HIS PHE ARG SEQRES 14 B 305 GLY ASP ARG SER LYS THR LEU LEU GLU LYS PRO LYS LEU SEQRES 15 B 305 PHE PHE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP ASP SEQRES 16 B 305 GLY ILE GLN ALA ASP SER GLY PRO ILE ASN ASP THR ASP SEQRES 17 B 305 ALA ASN PRO ARG TYR LYS ILE PRO VAL GLU ALA ASP PHE SEQRES 18 B 305 LEU PHE ALA TYR SER THR VAL PRO GLY TYR TYR SER TRP SEQRES 19 B 305 ARG SER PRO GLY ARG GLY SER TRP PHE VAL GLN ALA LEU SEQRES 20 B 305 CYS SER ILE LEU GLU GLU HIS GLY LYS ASP LEU GLU ILE SEQRES 21 B 305 MET GLN ILE LEU THR ARG VAL ASN ASP ARG VAL ALA ARG SEQRES 22 B 305 HIS PHE GLU SER GLN SER ASP ASP PRO HIS PHE HIS GLU SEQRES 23 B 305 LYS LYS GLN ILE PRO CYS VAL VAL SER MET LEU THR LYS SEQRES 24 B 305 GLU LEU TYR PHE SER GLN SEQRES 1 C 5 ACE ASP GLU VAL ASJ SEQRES 1 D 5 ACE ASP GLU VAL ASJ HET ACE C 701 3 HET ASJ C 705 8 HET ACE D 801 3 HET ASJ D 805 8 HET SO4 A1201 5 HET SO4 B1202 5 HETNAM ACE ACETYL GROUP HETNAM ASJ (3S)-3-AMINO-4-HYDROXYBUTANOIC ACID HETNAM SO4 SULFATE ION FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 ASJ 2(C4 H9 N O3) FORMUL 5 SO4 2(O4 S 2-) FORMUL 7 HOH *397(H2 O) HELIX 1 1 GLY A 89 GLY A 105 1 17 HELIX 2 2 SER A 115 GLU A 129 1 15 HELIX 3 3 ASP A 130 THR A 132 5 3 HELIX 4 4 ILE A 159 HIS A 165 1 7 HELIX 5 5 SER A 171 LEU A 175 5 5 HELIX 6 6 TRP A 240 GLY A 253 1 14 HELIX 7 7 GLU A 257 PHE A 273 1 17 HELIX 8 8 ASP A 279 HIS A 283 5 5 HELIX 9 9 ASP B 379 GLY B 383 5 5 HELIX 10 10 GLY B 389 GLY B 405 1 17 HELIX 11 11 SER B 415 GLU B 429 1 15 HELIX 12 12 ILE B 459 ALA B 464 1 6 HELIX 13 13 HIS B 465 ARG B 467 5 3 HELIX 14 14 SER B 471 LEU B 475 5 5 HELIX 15 15 TRP B 540 GLY B 553 1 14 HELIX 16 16 GLU B 557 PHE B 573 1 17 HELIX 17 17 ASP B 579 HIS B 583 5 5 SHEET 1 A12 PHE A 106 ASN A 112 0 SHEET 2 A12 LYS A 66 ASN A 74 1 O GLY A 68 N ASP A 107 SHEET 3 A12 ALA A 134 LEU A 142 1 N ALA A 135 O LYS A 66 SHEET 4 A12 LYS A 179 GLN A 184 1 N LEU A 180 O PHE A 137 SHEET 5 A12 PHE A 219 TYR A 223 1 O LEU A 220 N PHE A 181 SHEET 6 A12 CYS A 290 SER A 293 -1 O CYS A 290 N TYR A 223 SHEET 7 A12 CYS B 590 SER B 593 -1 O VAL B 591 N SER A 293 SHEET 8 A12 PHE B 519 TYR B 523 -1 O PHE B 521 N VAL B 592 SHEET 9 A12 LYS B 479 GLN B 484 1 O LYS B 479 N LEU B 520 SHEET 10 A12 ALA B 434 LEU B 442 1 O PHE B 437 N LEU B 480 SHEET 11 A12 LYS B 366 ASN B 374 1 O LYS B 366 N ALA B 435 SHEET 12 A12 PHE B 406 ASN B 412 1 N ASP B 407 O GLY B 368 SHEET 1 B 3 GLY A 145 GLU A 146 0 SHEET 2 B 3 VAL A 149 TYR A 151 -1 N VAL A 149 O GLU A 146 SHEET 3 B 3 VAL A 156 PRO A 158 -1 N THR A 157 O ILE A 150 SHEET 1 C 3 GLY A 238 SER A 239 0 SHEET 2 C 3 TRP A 232 SER A 234 -1 O SER A 234 N GLY A 238 SHEET 3 C 3 GLU C 703 VAL C 704 -1 N GLU C 703 O ARG A 233 SHEET 1 D 3 GLY B 445 GLU B 446 0 SHEET 2 D 3 VAL B 449 TYR B 451 -1 N VAL B 449 O GLU B 446 SHEET 3 D 3 VAL B 456 PRO B 458 -1 O THR B 457 N ILE B 450 SHEET 1 E 2 GLY B 488 GLU B 490 0 SHEET 2 E 2 GLY B 528 TYR B 529 1 O GLY B 528 N GLU B 490 SHEET 1 F 3 GLY B 538 SER B 539 0 SHEET 2 F 3 TRP B 532 SER B 534 -1 O SER B 534 N GLY B 538 SHEET 3 F 3 GLU D 803 VAL D 804 -1 O GLU D 803 N ARG B 533 LINK SG CYS A 186 C ASJ C 705 1555 1555 1.80 LINK SG CYS B 486 C ASJ D 805 1555 1555 1.85 LINK C ACE C 701 N ASP C 702 1555 1555 1.31 LINK C ACE D 801 N ASP D 802 1555 1555 1.35 LINK C VAL C 704 N ASJ C 705 1555 1555 1.35 LINK C VAL D 804 N ASJ D 805 1555 1555 1.33 SITE 1 AC1 7 LYS A 76 ASN A 88 GLY A 89 THR A 90 SITE 2 AC1 7 ASP A 91 LYS A 92 HOH A1136 SITE 1 AC2 7 LYS B 376 GLY B 389 THR B 390 ASP B 391 SITE 2 AC2 7 LYS B 392 LYS B 399 HOH B 775 SITE 1 AC3 17 ARG A 87 ASN A 88 SER A 143 HIS A 144 SITE 2 AC3 17 GLY A 145 GLN A 184 CYS A 186 TYR A 230 SITE 3 AC3 17 SER A 231 TRP A 232 ARG A 233 SER A 234 SITE 4 AC3 17 PRO A 235 SER A 275 GLN A 276 HOH C 921 SITE 5 AC3 17 HOH C1130 SITE 1 AC4 16 ARG B 387 HIS B 444 GLY B 445 GLN B 484 SITE 2 AC4 16 CYS B 486 SER B 531 TRP B 532 ARG B 533 SITE 3 AC4 16 SER B 534 PRO B 535 SER B 575 GLN B 576 SITE 4 AC4 16 HOH B 920 HOH D 807 HOH D 808 HOH D 809 CRYST1 88.180 88.180 186.230 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011340 0.006547 0.000000 0.00000 SCALE2 0.000000 0.013095 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005370 0.00000